Randomized Trialhigh evidence
Low-Voltage Area Ablation for Persistent Atrial Fibrillation: The COAST-AF Randomized Clinical Trial.
JAMA·November 8, 2026·PMID 42999998
Why it mattersPersistent AF ablation outcomes remain suboptimal, and identifying patients who benefit from substrate modification is a key clinical challenge. This trial provides randomized evidence that LVA-guided ablation may improve arrhythmia-free survival specifically in patients with atrial low-voltage areas, potentially refining patient selection for more extensive ablation.

The papers that matter, first.
MedLit ranks the medical literature into a specialty feed with concise summaries, evidence-aware triage, and visual takeaways.
§
MedLit · Evidence, Distilled